• Golgi-Tracker Green: Live-Cell Imaging Workflow

  2026-09-18

  Build a reproducible live-cell Golgi imaging workflow for organelle morphology, lipid trafficking, and sphingolipid metabolism analysis. This guide also shows how to interpret Golgi fragmentation in oncology experiments without confusing a structural assay with a therapeutic mechanism.

• SAR405: Vps34 Inhibition Beyond Autophagy

  2026-09-18

  SAR405 is a selective Vps34 inhibitor for dissecting autophagy, vesicle trafficking, and emerging nuclear PI3P control of DNA mismatch repair. This article translates recent mechanistic findings into practical assay decisions while separating established evidence from testable hypotheses.

• Camostat Mesilate: From Protease Assays to PPIs

  2026-09-17

  Camostat Mesilate is a trypsin-like protease inhibitor whose value depends on matching the compound to the correct biological readout. This article connects ENaC and fibrosis workflows with structure-guided PPI research while clarifying what can—and cannot—be transferred between assay domains.

• PPARγ and Macrophage Polarization in DSS Colitis

  2026-09-17

  A 2025 study links PPARγ activation to improved DSS-induced colitis by shifting macrophages away from STAT-1-associated M1 polarization toward STAT-6-associated M2 features. Its combined cell and mouse design provides a useful framework for studying nuclear-receptor control of intestinal inflammation, while also clarifying the limits of translating agonist findings into antagonist-based metabolic research.

• Hypoxia, Immunometabolism, and Tumor Redox State

  2026-09-16

  This 2025 review frames tumor hypoxia and immune metabolic reprogramming as a self-reinforcing system that links oxygen limitation, nutrient competition, immune dysfunction, and malignant progression. Its main practical contribution is an integrated framework for designing studies that measure tumor metabolism, immune-cell state, and redox biology together rather than as isolated variables.

• (R,S)-Anatabine Workflows for Aβ Research

  2026-09-16

  (R,S)-Anatabine supports mechanism-resolved studies of amyloid precursor protein processing, soluble Aβ peptide reduction, and NF-κB signaling. This workflow guide shows how to integrate Anatabine into neuronal cell assays and short-duration in vivo Alzheimer's disease model studies while controlling solvent, sampling, and interpretation variables.

• Licoricidin Targets PI3K/AKT in Liver Cancer

  2026-09-15

  The reference study shows that licoricidin, a prenylated isoflavone from Glycyrrhiza uralensis, inhibits hepatocellular carcinoma cell growth, migration, invasion, and tumor progression in experimental models. Its findings connect apoptosis, S-phase arrest, epithelial–mesenchymal transition, and PI3K/AKT pathway suppression, while also highlighting the need for clinical and mechanistic validation.

• Sodium Orthovanadate in Translational Insulin Signaling

  2026-09-15

  Sodium Orthovanadate (Na3VO4) is more than a routine phosphatase additive: its reversible, broad inhibition profile can help preserve phosphorylation-dependent evidence in insulin-resistance research while also creating important assay controls. This article connects mechanism, protocol design, product selection, and translational interpretation around PI-3K/AKT/GLUT4 signaling.

• URB597 (KDS-4103) in FAAH Research

  2026-09-14

  URB597 (KDS-4103) offers a selective way to elevate anandamide and isolate FAAH-dependent endocannabinoid biology. This practical guide connects formulation, biochemical target engagement, LC-MS/MS, neuronal assays, and pain-related behavioral workflows while highlighting the limits of translating FAAH inhibition into complex inflammatory models.

• HyperScript™ Reverse Transcriptase for RNA

  2026-09-14

  HyperScript™ Reverse Transcriptase is designed for demanding RNA-to-cDNA workflows involving structured transcripts, long targets, or limited input. This practical guide shows how to apply it to qPCR validation and hypothalamic gene-expression studies while improving controls, temperature selection, and troubleshooting.

• Substance P Workflows for Pain and Inflammation

  2026-09-13

  Build reproducible Substance P experiments around fresh aqueous handling, receptor-aware controls, and matrix-conscious readouts. This workflow also adapts spectral preprocessing lessons from bioaerosol classification to improve assay quality control without confusing fluorescence signatures with pharmacological evidence.

• Hesperadin: Aurora B Kinase Inhibitor Workflow

  2026-09-12

  Hesperadin provides an acute, tunable way to interrogate Aurora B-dependent mitosis, from histone H3 Ser-10 phosphorylation to chromosome segregation and cytokinesis. This workflow combines quantitative dosing, checkpoint-focused controls, and troubleshooting guidance for cell cycle research and cancer research.

• Camostat Mesilate: Protease & Fibrosis Research

  2026-09-11

  Camostat Mesilate is a trypsin-like protease inhibitor used to study ENaC function, plasmin-dependent TGF-β signaling, and hepatic fibrosis. Its reported ENaC IC50 is 50 nM, while its fibrosis evidence remains preclinical and should not be conflated with structure-guided antiviral PPI inhibitors.

• Direct Mouse Genotyping Kit Plus Workflow

  2026-09-11

  Build a rapid, purification-free mouse genotyping workflow for transgene confirmation, knockout screening, and colony management. The Direct Mouse Genotyping Kit Plus combines direct tissue lysate preparation with a PCR master mix with dye reagents, helping researchers connect genotype decisions to complex experimental phenotypes.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-10

  The reference study identifies circulating moesin as a candidate marker of endothelial injury and sepsis severity, linking clinical measurements with mouse and endothelial-cell experiments. Its results connect moesin to Rock1/myosin light chain and NF-κB signaling, while also defining practical limits for translating the findings into mechanistic or therapeutic studies.

8564 records 1/571 page Next 12345 下5页 Last page